Vaccinex director resigns, no disagreement cited

Published 19/03/2025, 21:26
Vaccinex director resigns, no disagreement cited

ROCHESTER, NY – Vaccinex (OTC:VCNX), Inc., a biotechnology company specializing in pharmaceutical preparations with a current market capitalization of $1.66 million, announced the immediate resignation of Bala S. Manian from its board of directors, as detailed in the company’s recent 8-K filing with the Securities and Exchange Commission.

The departure, which took place on Monday, was not due to any disputes or disagreements over the company’s operations, policies, or practices, according to the filing. The company, headquartered at 1895 Mount Hope Avenue, Rochester, New York, has not yet indicated a successor or provided details on the search for a new director.

Vaccinex, trading on the Nasdaq Capital Market under the ticker NASDAQ:VCNX, is incorporated in Delaware and operates within the pharmaceutical industry, with a focus on developing treatments and drugs.

This move comes amidst a period where corporate governance and the composition of company boards are under increasing scrutiny by investors and regulators alike. However, the company’s brief statement offered no further context for Mr. Manian’s resignation, nor did it elaborate on any upcoming changes to the board’s structure or strategic direction.

The information regarding this corporate event is based on the company’s official statement in a press release. Vaccinex has not disclosed any further information on the matter at this time.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.